The impact of curcumin on breast cancer

EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1

(2014) Shala L. Thomas et al.   CELL CYCLE

The Targets of Curcumin

(2012) Hongyu Zhou et al.   CURRENT DRUG TARGETS

Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA

(2012) S. Volinia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone

(2011) Jeffrey D Altenburg et al.   BMC CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Stabilisation and Knockdown of HIF - Two Distinct Ways Comparably Important in Radiotherapy

(2011) Mareike Ströfer et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Curcumin Decreases Survival of Hep3B Liver and MCF-7 Breast Cancer Cells

(2011) Mareike Ströfer et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals

(2010) Bharat B. Aggarwal   Annual Review of Nutrition

The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells

(2010) Mathanaporn Boonrao et al.   ARCHIVES OF PHARMACAL RESEARCH

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

(2010) Chandana Mohanty et al.   BIOMATERIALS

Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S. - a SEER analysis

(2010) Madhuri Kakarala et al.   BMC CANCER

Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies

(2010) Gulrana Khuwaja et al.   BRAIN RESEARCH

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

(2010) Ensaf M. Al-Hujaily et al.   BREAST CANCER RESEARCH AND TREATMENT

Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

(2010) Mathilde Bayet-Robert et al.   CANCER BIOLOGY & THERAPY

Common Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer

(2010) A. Slusarz et al.   CANCER RESEARCH

Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells

(2010) Wen-Feng Hua et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells

(2010) Mithu Banerjee et al.   FEBS Journal

Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells

(2010) Jyoti Nautiyal et al.   INTERNATIONAL JOURNAL OF CANCER

The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity

(2010) Matthew A Bill et al.   Molecular Cancer

Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth

(2010) Murali M Yallapu et al.   Journal of Ovarian Research

Curcumin as a Possible Lead Compound against Hormone-Independent, Multidrug-Resistant Breast Cancer

(2009) Manuela Labbozzetta et al.   Annals of the New York Academy of Sciences

Structure–activity relationship studies of curcumin analogues

(2009) James R. Fuchs et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231

(2009) Yew Cheah et al.   Cancer Cell International

Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo

(2009) Hiroyuki Shibata et al.   CANCER SCIENCE

Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signaling

(2009) Chandra P. Prasad et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Resistance to Trastuzumab in Breast Cancer

(2009) P. R. Pohlmann et al.   CLINICAL CANCER RESEARCH

Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions

(2009) Chuan-Chuan Lin et al.   FOOD CHEMISTRY

Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells

(2009) Mi Jin Yoon et al.   FREE RADICAL BIOLOGY AND MEDICINE

Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model

(2009) Ajaikumar B. Kunnumakkara et al.   INTERNATIONAL JOURNAL OF CANCER

A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer

(2009) Ikuo Sekine et al.   International Journal of Clinical Oncology

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

(2009) Heikki Joensuu et al.   JOURNAL OF CLINICAL ONCOLOGY

Fluorocurcumins as Cyclooxygenase-2 Inhibitor: Molecular Docking, Pharmacokinetics and Tissue Distribution in Mice

(2009) Subhash Padhye et al.   PHARMACEUTICAL RESEARCH

Analysis of Binding Interaction of Curcumin and Diacetylcurcumin with Human and Bovine Serum Albumin Using Fluorescence and Circular Dichroism Spectroscopy

(2009) Fakhrossadat Mohammadi et al.   PROTEIN JOURNAL

Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics

(2009) Junichi Kurebayashi   Breast Cancer

Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

(2008) Ajaikumar B. Kunnumakkara et al.   CANCER LETTERS

Curcumin Inhibition of Integrin ( 6 4)-Dependent Breast Cancer Cell Motility and Invasion

(2008) H. I. Kim et al.   Cancer Prevention Research

Osteopontin Promotes Vascular Endothelial Growth Factor Dependent Breast Tumor Growth and Angiogenesis via Autocrine and Paracrine Mechanisms

(2008) G. Chakraborty et al.   CANCER RESEARCH

Curcumin: From ancient medicine to current clinical trials

(2008) H. Hatcher et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

“New” molecular taxonomy in breast cancer

(2008) Marta Hergueta-Redondo et al.   Clinical & Translational Oncology

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

(2008) N. Dhillon et al.   CLINICAL CANCER RESEARCH

Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa

(2008) Mamoru Shoji et al.   JOURNAL OF DRUG TARGETING

Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA

(2008) Supachai Yodkeeree et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells

(2008) M. Sun et al.   MOLECULAR CANCER THERAPEUTICS

Inhibition of I B Kinase-Nuclear Factor- B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin

(2008) A. L. Kasinski et al.   MOLECULAR PHARMACOLOGY

Anti-ischemic Effect of Curcumin in Rat Brain

(2008) Pradeep K. Shukla et al.   NEUROCHEMICAL RESEARCH

Recent advances in the investigation of curcuminoids

(2008) Hideji Itokawa et al.   Chinese Medicine